Sequana Medical NV (SEQUA.BR)
EUR 1.43
(-4.67%)
EUR 1.43
(-4.67%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 29.56 Million EUR | 4.92% |
| 2022 | 28.17 Million EUR | 81.89% |
| 2021 | 15.49 Million EUR | 9.87% |
| 2020 | 14.1 Million EUR | 67.38% |
| 2019 | 8.42 Million EUR | -61.88% |
| 2018 | 22.1 Million EUR | 171.85% |
| 2017 | 8.12 Million EUR | -22.39% |
| 2016 | 10.47 Million EUR | 110.92% |
| 2015 | 4.96 Million EUR | 55.52% |
| 2014 | 3.19 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 30.35 Million EUR | 2.65% |
| 2024 Q2 | 30.35 Million EUR | 0.0% |
| 2023 Q3 | 29.56 Million EUR | 2.88% |
| 2023 Q1 | 28.73 Million EUR | 1.98% |
| 2023 FY | 29.56 Million EUR | 4.92% |
| 2023 Q2 | 28.73 Million EUR | 0.0% |
| 2023 Q4 | 29.56 Million EUR | 0.0% |
| 2022 Q2 | 17.7 Million EUR | 0.0% |
| 2022 FY | 28.17 Million EUR | 81.89% |
| 2022 Q3 | 28.17 Million EUR | 59.13% |
| 2022 Q4 | 28.17 Million EUR | 0.0% |
| 2022 Q1 | 17.7 Million EUR | 14.3% |
| 2021 Q2 | 14.78 Million EUR | 0.0% |
| 2021 FY | 15.49 Million EUR | 9.87% |
| 2021 Q4 | 15.49 Million EUR | 0.0% |
| 2021 Q3 | 15.49 Million EUR | 4.78% |
| 2021 Q1 | 14.78 Million EUR | 4.86% |
| 2020 FY | 14.1 Million EUR | 67.38% |
| 2020 Q4 | 14.1 Million EUR | -0.0% |
| 2020 Q3 | 14.1 Million EUR | 60.55% |
| 2020 Q2 | 8.78 Million EUR | -0.0% |
| 2020 Q1 | 8.78 Million EUR | 4.25% |
| 2019 FY | 8.42 Million EUR | -61.88% |
| 2019 Q2 | 7.58 Million EUR | 0.0% |
| 2019 Q1 | 7.58 Million EUR | -65.66% |
| 2019 Q4 | 8.42 Million EUR | -0.0% |
| 2019 Q3 | 8.42 Million EUR | 11.0% |
| 2018 Q3 | 15.96 Million EUR | 0.0% |
| 2018 FY | 22.1 Million EUR | 171.85% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 Q4 | 22.1 Million EUR | 38.41% |
| 2017 Q4 | 8.12 Million EUR | 0.0% |
| 2017 FY | 8.12 Million EUR | -22.39% |
| 2016 FY | 10.47 Million EUR | 110.92% |
| 2015 FY | 4.96 Million EUR | 55.52% |
| 2014 FY | 3.19 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Affluent Medical SA | 25.15 Million EUR | -17.555% |
| Bluelinea Société Anonyme | 8.86 Million EUR | -233.527% |
| Carmat SA | 96.83 Million EUR | 69.466% |
| Diagnostic Medical Systems S.A. | 37.41 Million EUR | 20.98% |
| Euromedis Groupe | 23.66 Million EUR | -24.926% |
| Eurobio Scientific Société anonyme | 141.15 Million EUR | 79.054% |
| Ikonisys S.A. | 5.11 Million EUR | -477.471% |
| Implanet S.A. | 10.81 Million EUR | -173.483% |
| Median Technologies SA | 46.22 Million EUR | 36.043% |
| SpineGuard SA | 5 Million EUR | -490.922% |
| Theraclion SA | 13.01 Million EUR | -127.143% |
| Euroapi S.A. | 684.7 Million EUR | 95.682% |
| Guerbet SA | 646.97 Million EUR | 95.43% |
| Ion Beam Applications SA | 490.44 Million EUR | 93.972% |
| Koninklijke Philips N.V. | 17.63 Billion EUR | 99.832% |